A comparative study of insulin resistance for Saudi and Caucasian subjects across a range of glycaemic categories

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 3, Issue 4, 2009, Pages 204-210

  Borai, Anwar ^a   Livingstone, Callum ^a,b   Zarif, Hawazen ^c   Mehta, Shweta ^b   Kholeif, Mona ^c   Abdelaal, Mohammed ^c   Al Ghamdi, Hanin ^c   Ferns, Gordon ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Caucasian; FSIVGTT; IGFBP 1; Insulin sensitivity (Si); Saudi

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SAUDI ARABIA;

EID: 70849113511     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2009.07.013     Document Type: Article

References (37)

1. Beck-Nielsen H. General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR). Drugs 58 Suppl. 1 (1999) 7-10 [discussion 75-82]
2. Al-Nozha M., Al-Khadra A., Arafah M.R., Al-Maatouq M.A., Khalil M.Z., Khan N.B., et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 26 12 (2005) 1918-1925
3. Karim A., Ogbeide D.O., Siddiqui S., and Al-Khalifa I.M. Prevalence of diabetes mellitus in a Saudi community. Saudi Med J 21 5 (2000) 438-442
4. Al-Hazzaa H.M. Prevalence of physical inactivity in Saudi Arabia: a brief review. East Mediterr Health J 10 4-5 (2004) 663-670
5. Heald A.H., Anderson S.G., Vyas A., Siddals K., Patel J., Yates A.P., et al. Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India. Diabetologia 48 9 (2005) 1756-1765
6. Alissa E.M., Bahijri S.M., and Ferns G.A. Dietary macronutrient intake of Saudi males and its relationship to classical coronary risk factors. Saudi Med J 26 2 (2005) 201-207
7. Lillioja S., Mott D.M., Howard B.V., Bennett P.H., Yki-Jarvinen H., Freymond D., et al. Impaired glucose tolerance as a disorder of insulin action longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318 19 (1988) 1217-1225
8. Borai A., Livingstone C., and Ferns G. The biochemical assessment of insulin resistance. Ann Clin Biochem 44 (2007) 324-342
9. Heald A.H., Cruickshank J.K., Riste L.K., Cade J.E., Anderson S., Greenhalgh A., et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44 3 (2001) 333-339
10. McKeigue P.M., Shah B., and Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337 8738 (1991) 382-386
11. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 1 (1995) 3-34
12. Lee P.D., Conover C.A., and Powell D.R. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204 1 (1993) 4-29
13. Jones J.I., D'Ercole A.J., Camacho-Hubner C., and Clemmons D.R. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88 17 (1991) 7481-7485
14. Rajaram S., Baylink D.J., and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18 6 (1997) 801-831
15. Westwood M., Gibson J.M., Davies A.J., Young R.J., and White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79 6 (1994) 1735-1741
16. Kousta E., Lawrence N.J., Godsland I.F., Penny A., Anyaoku V., Millauer B.A., et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 59 3 (2003) 289-297
17. Flanagan D.E., Holt R.I., Owens P.C., Cockington R.J., Moore V.M., Robinson J.S., et al. Gender differences in the insulin-like growth factor axis response to a glucose load. Acta Physiol (Oxf) 187 3 (2006) 371-378
18. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 7 (1998) 539-553
19. Bergman R.N., Ider Y.Z., Bowden C.R., and Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 236 6 (1979) E667-E677
20. Bergman R.N., Prager R., Volund A., and Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79 3 (1987) 790-800
21. Boston R.C., Stefanovski D., Moate P.J., Sumner A.E., Watanabe R.M., Bergman R.N., et al. Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5 6 (2003) 1003-1015
22. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 6 (2004) 1487-1495
23. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 7 (2000) 2402-2410
24. Belfiore F., Iannello S., and Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63 2 (1998) 134-141
25. Liew C.F., Wise S.D., Yeo K.P., and Lee K.O. Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men. J Clin Endocrinol Metab 90 3 (2005) 1483-1488
26. Araujo-Vilar D., Rega-Liste C.A., Garcia-Estevez D.A., Sarmiento-Escalona F., Mosquera-Tallon V., and Cabezas-Cerrato J. Minimal model of glucose metabolism: modified equations and its application in the study of insulin sensitivity in obese subjects. Diabetes Res Clin Pract 39 2 (1998) 129-141
27. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
28. Zimmet P., KG M.M.A., and Serrano Rios M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 58 12 (2005) 1371-1376
29. World UN. Population Propsects: revision for 2005-2010 Table A.17; 2006.
30. Osei K., Rhinesmith S., Gaillard T., and Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 27 6 (2004) 1439-1446
31. Zizek B., Poredos P., Trojar A., and Zeljko T. Diastolic dysfunction is associated with insulin resistance, but not with aldosterone level in normotensive offspring of hypertensive families. Cardiology 111 1 (2008) 8-15
32. Brancati F.L., Kao W.H., Folsom A.R., Watson R.L., and Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283 17 (2000) 2253-2259
33. Lillioja S., Mott D.M., Zawadzki J.K., Young A.A., Abbott W.G., Knowler W.C., et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36 11 (1987) 1329-1335
34. Carnevale Schianca G.P., Sainaghi P.P., Castello L., Rapetti R., Limoncini A.M., and Bartoli E. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome. Diabetes Metab Res Rev 22 2 (2006) 111-117
35. Maddux B.A., Chan A., Mandarino L.J., and Goldfine I.D. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29 7 (2006) 1535-1537
36. Youngren J.F. Regulation of insulin receptor function. Cell Mol Life Sci 64 7-8 (2007) 873-891
37. Nyomba B.L., Berard L., and Murphy L.J. Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82 7 (1997) 2177-2181